TOSOH BIOSCIENCE, INC. FDA Inspection Record
TOSOH BIOSCIENCE, INC. is an FDA-registered facility (FEI 3005529799) located in Grove City, OH, US. RegDataLab tracks 6 FDA inspections and 2 compliance actions at this facility.
What FDA found at this site
- Latest inspection
- Oct 11, 2019: Voluntary Action Indicated (VAI)
- Inspections on record
- 6 (3 OAI, 2 VAI, 1 NAI)
- Last OAI inspection
- Jun 28, 2016
- Warning letters
- 2 listed by FDA for this FEI, latest Aug 5, 2016
- Recalls as the recalling firm
- 23, latest Jun 12, 2026
Inspections and what FDA cited
| Date | Result | What FDA cited |
|---|---|---|
| Oct 11, 2019 | Voluntary Action Indicated (VAI) | Lack of or inadequate procedures (21 CFR 820.100(a)) Production processes (21 CFR 820.70(a)) |
| Oct 16, 2018 | No Action Indicated (NAI) | Lack of or inadequate procedures (21 CFR 820.100(a)) Nonconforming product, Lack of or inadequate procedures (21 CFR 820.90(a)) Servicing - Lack of or inadequate procedures (21 CFR 820.200(a)) Lack of or inadequate process validation (21 CFR 820.75(a)) |
| Jun 28, 2016 | Official Action Indicated (OAI) | Quality audits - Lack of or inadequate procedures (21 CFR 820.22) Lack of or inadequate procedures (21 CFR 820.100(a)) Investigation of device failures (21 CFR 820.198(c)) Maintenance schedule, Lack of or inadequate schedule (21 CFR 820.70(g)(1)) and 2 more |
| Jun 17, 2011 | Voluntary Action Indicated (VAI) | Design transfer - Lack of or inadequate procedures (21 CFR 820.30(h)) Design changes - Lack of or Inadequate Procedures (21 CFR 820.30(i)) Design history file (21 CFR 820.30(j)) Lack of or inadequate procedures (21 CFR 820.100(a)) and 2 more |
| Aug 5, 2010 | Official Action Indicated (OAI) | No citations listed |
| May 27, 2010 | Official Action Indicated (OAI) | No citations listed |
Recalls
| Date | Class | Recall | Product and reason |
|---|---|---|---|
| Jun 12, 2026 | Class II | Z-2746-2026 | ST AIA-Pack Testosterone, IN VITRO DIAGNOSTIC USE ONLY for the quantitative measurement of… The Test cup lot F level 1 low-quality control results values for the device were lower than expected on the Automated Immunoassay Analyzer… |
| Aug 7, 2020 | Class II | Z-2967-2020 | Tosoh Bioscience AIA- PACK HCG Calibrator Set-In Vitro Diagnostic for BHCG
Part number… and 1 more product Decreased stability for five (5) lots of Calibrator Sets and Calibration Verification Test Sets, resulting in a decrease measured… |
| May 22, 2020 | Class II | Z-2423-2020 | AIA-900 Analyzer, Part no. 022930, UDI 04560189283992 The Substrate Monitoring System in the AIA-900 Analyzer did not detect an empty substrate bottle. The issue may lead to erroneous… |
| Jan 10, 2020 | Class II | Z-1420-2020 | AIA-360 Automated Immunoassay Analyzer, Product Code 019945 A display screen software issue on the analyzer causes the display to freeze when display screen is touched at the same time as a command… |
| Nov 30, 2018 | Class II | Z-0671-2019 | AIA-PACK B12 (Vitamin B12) is designed for IN VITRO DIAGNOSTIC USE ONLY for the… and 5 more products Potential for fluorescein interference to cause inaccurately elevated results for certain Tosoh AIA assays |
| Oct 5, 2018 | Class II | Z-0469-2019 | AIA-900 Analyzer, Product code 022930, 022930R Tosoh Bioscience has become aware of a potential issue with the pickup arm and pickup arm motor on the AIA-900 Analyzer. If the pickup arm… |
| Oct 5, 2018 | Class II | Z-0509-2019 | AIA-900 Automated Immunoassay Analyzer, product code 022930 /022930R
Product… Tosoh Bioscience has become aware of a potential issue with the axis base of the turntable rotation drive motor on the AIA-900 Analyzer. If… |
| Oct 5, 2018 | Class III | Z-0601-2019 | Hemoglobin A1c Control, Part no. 220232 for use as quality control material to monitor the… Tosoh Bioscience has become aware of potential degradation of HbA1c control lot # 7055 before the 60-days product stability claim. If… |
| Sep 28, 2018 | Class II | Z-0475-2019 | AIA-2000 Analyzer, Model Nos. AIA-2000LA, AIA-2000ST - Product Usage: The AIA-2000 is… There is a possibility that the liquid suction pump on some AIA-2000 analyzers may not perform as intended and cause an insufficient volume… |
| Sep 28, 2018 | Class II | Z-0485-2019 | Tosoh AIA-900 immunoassay Analyzer A software issue may cause the liquid volume detection entries for 2nd and 3rd reagent bottles to be overwritten with the data from the 1st… |
FDA record score
24 of 100. A count of this site's adverse public FDA records, weighted by how recent each one is. A higher number means more, or more recent, records. Each record below adds the points shown.
27 records behind this number
| Record | Date | Points x age weight | Adds |
|---|---|---|---|
| Class II recall Z-2746-2026, this FEI as the recalling firm | Jun 12, 2026 | 4 x 1 | 4 |
| Inspection classified VAI | Oct 11, 2019 | 6 x 0.25 | 1.5 |
| Class II recall Z-2967-2020, this FEI as the recalling firm | Aug 7, 2020 | 4 x 0.25 | 1 |
| Class II recall Z-2423-2020, this FEI as the recalling firm | May 22, 2020 | 4 x 0.25 | 1 |
| Class II recall Z-1420-2020, this FEI as the recalling firm | Jan 10, 2020 | 4 x 0.25 | 1 |
| Class II recall Z-0671-2019, this FEI as the recalling firm | Nov 30, 2018 | 4 x 0.25 | 1 |
| Class II recall Z-0469-2019, this FEI as the recalling firm | Oct 5, 2018 | 4 x 0.25 | 1 |
| Class II recall Z-0509-2019, this FEI as the recalling firm | Oct 5, 2018 | 4 x 0.25 | 1 |
| Class II recall Z-0475-2019, this FEI as the recalling firm | Sep 28, 2018 | 4 x 0.25 | 1 |
| Class II recall Z-0485-2019, this FEI as the recalling firm | Sep 28, 2018 | 4 x 0.25 | 1 |
| Class II recall Z-0599-2019, this FEI as the recalling firm | Sep 28, 2018 | 4 x 0.25 | 1 |
| Class II recall Z-0559-2019, this FEI as the recalling firm | Aug 23, 2018 | 4 x 0.25 | 1 |
| Class II recall Z-3244-2018, this FEI as the recalling firm | Jul 13, 2018 | 4 x 0.25 | 1 |
| Class II recall Z-2745-2018, this FEI as the recalling firm | Jun 6, 2018 | 4 x 0.25 | 1 |
| Class II recall Z-1809-2018, this FEI as the recalling firm | Mar 5, 2018 | 4 x 0.25 | 1 |
| Class II recall Z-2065-2018, this FEI as the recalling firm | Mar 5, 2018 | 4 x 0.25 | 1 |
| Class II recall Z-0825-2018, this FEI as the recalling firm | Feb 13, 2018 | 4 x 0.25 | 1 |
| Class II recall Z-0602-2019, this FEI as the recalling firm | Sep 28, 2017 | 4 x 0.25 | 1 |
| Class II recall Z-0491-2018, this FEI as the recalling firm | Jun 11, 2017 | 4 x 0.25 | 1 |
| Class II recall Z-0613-2019, this FEI as the recalling firm | Mar 22, 2017 | 4 x 0.25 | 1 |
| Warning letter on FDA's dashboard, which does not show close-outs | Aug 5, 2016 | 10 years or older, so it adds no points | 0 |
| Inspection classified OAI | Jun 28, 2016 | 10 years or older, so it adds no points | 0 |
| Class II recall Z-1187-2021, this FEI as the recalling firm | Feb 23, 2012 | 10 years or older, so it adds no points | 0 |
| Inspection classified VAI | Jun 17, 2011 | 10 years or older, so it adds no points | 0 |
| Warning letter on FDA's dashboard, which does not show close-outs | Jan 18, 2011 | 10 years or older, so it adds no points | 0 |
| Inspection classified OAI | Aug 5, 2010 | 10 years or older, so it adds no points | 0 |
| Inspection classified OAI | May 27, 2010 | 10 years or older, so it adds no points | 0 |
When each source was last refreshed
| Records | Last refreshed | Source as of | Status |
|---|---|---|---|
| Inspections | Nov 22, 2026 | Newest record Nov 9, 2026 | Current |
| Inspection citations | Nov 22, 2026 | Newest record Nov 5, 2026 | Current |
| Compliance actions (warning letters, injunctions and other action types) | Nov 22, 2026 | Newest record Nov 13, 2026 | Current |
| Warning letter text | Nov 22, 2026 | Newest record Nov 17, 2026 | Current |
| Recalls (Enforcement Report) | Nov 22, 2026 | Newest record Nov 18, 2026 | Current |
| Form 483s and inspection documents | Nov 18, 2026 | Newest record Nov 17, 2026 | Current |
| Import refusals | Nov 22, 2026 | Newest record Nov 12, 2026 | Current |
Reviewing TOSOH BIOSCIENCE, INC. as a supplier? Request a free FDA snapshot: name up to five suppliers and get a PDF of their public FDA record, with sources and dates. You do not need an API connection. Each snapshot is prepared by hand.
Or check TOSOH BIOSCIENCE, INC. yourself in Claude, Cursor or ChatGPT: get the full FDA risk summary, with inspections, warning letters, Form 483s and import alerts by site.
Facility details
- Company
- Tosoh Bioscience Inc
- Location
- Grove City, OH (US)
- Source
- device